Li L[au] - Search Results

Year	Number of Results
1947	2
1948	1
1949	1
1957	1
1959	3
1960	5
1961	1
1962	3
1963	7
1964	4
1965	5
1966	5
1967	4
1968	3
1969	1
1970	4
1971	8
1972	4
1973	2
1974	6
1975	3
1976	8
1977	6
1978	7
1979	12
1980	8
1981	17
1982	18
1983	20
1984	33
1985	25
1986	35
1987	54
1988	53
1989	65
1990	89
1991	99
1992	123
1993	168
1994	147
1995	174
1996	177
1997	229
1998	248
1999	297
2000	394
2001	422
2002	497
2003	672
2004	768
2005	999
2006	1133
2007	1373
2008	1612
2009	1849
2010	2253
2011	2619
2012	3136
2013	3636
2014	4239
2015	4808
2016	5188
2017	5517
2018	6254
2019	7105
2020	8719
2021	9837
2022	6805
2023	2

1

Retracted: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.

Li L, Huizhi L, Binu W, Xinxin D, Longjun W, Liping Y, Yingying Z. Li L, et al. Med Sci Monit. 2022 Jul 19;28:e937840. doi: 10.12659/MSM.937840. Med Sci Monit. 2022. PMID: 35850997 Free article.

2

Cholesterol Biosynthesis Modulates CSFV Replication.

Zou X, Lin F, Yang Y, Chen J, Zhang H, Li L, Ouyang H, Pang D, Tang X. Zou X, et al. Among authors: li l. Viruses. 2022 Jun 30;14(7):1450. doi: 10.3390/v14071450. Viruses. 2022. PMID: 35891429 Free PMC article.

3

Preclinical Cold Atmospheric Plasma Cancer Treatment.

Limanowski R, Yan D, Li L, Keidar M. Limanowski R, et al. Among authors: li l. Cancers (Basel). 2022 Jul 16;14(14):3461. doi: 10.3390/cancers14143461. Cancers (Basel). 2022. PMID: 35884523 Free PMC article. Review.

4

Generation of αGal-enhanced bifunctional tumor vaccine.

He J, Huo Y, Zhang Z, Luo Y, Liu X, Chen Q, Wu P, Shi W, Wu T, Tang C, Wang H, Li L, Liu X, Huang Y, Zhao Y, Gan L, Wang B, Zhong L. He J, et al. Among authors: li l. Acta Pharm Sin B. 2022 Jul;12(7):3177-3186. doi: 10.1016/j.apsb.2022.03.002. Epub 2022 Mar 9. Acta Pharm Sin B. 2022. PMID: 35865091 Free PMC article.

5

Ionic Liquids: Emerging Antimicrobial Agents.

Fang Z, Zheng X, Li L, Qi J, Wu W, Lu Y. Fang Z, et al. Among authors: li l. Pharm Res. 2022 Jul 25. doi: 10.1007/s11095-022-03336-5. Online ahead of print. Pharm Res. 2022. PMID: 35879499 Review.

6

A nonneglectable stereochemical factor in drug development: Atropisomerism.

Yang YD, Yang BB, Li L. Yang YD, et al. Among authors: li l. Chirality. 2022 Jul 29. doi: 10.1002/chir.23497. Online ahead of print. Chirality. 2022. PMID: 35904531 Review.

7

Stimuli-Responsive Gold Nanocages for Cancer Diagnosis and Treatment.

Li C, Zhao T, Li L, Hu X, Li C, Chen W, Hu Y. Li C, et al. Among authors: li l. Pharmaceutics. 2022 Jun 22;14(7):1321. doi: 10.3390/pharmaceutics14071321. Pharmaceutics. 2022. PMID: 35890217 Free PMC article. Review.

8

Photodegradation and Photostability of Bamboo: Recent Advances.

Rao F, Li X, Li N, Li L, Liu Q, Wang J, Zhu X, Chen Y. Rao F, et al. Among authors: li l. ACS Omega. 2022 Jul 6;7(28):24041-24047. doi: 10.1021/acsomega.2c02035. eCollection 2022 Jul 19. ACS Omega. 2022. PMID: 35874254 Free PMC article. Review.

9

Dietary-Nutraceutical Properties of Oat Protein and Peptides.

Rafique H, Dong R, Wang X, Alim A, Aadil RM, Li L, Zou L, Hu X. Rafique H, et al. Among authors: li l. Front Nutr. 2022 Jul 5;9:950400. doi: 10.3389/fnut.2022.950400. eCollection 2022. Front Nutr. 2022. PMID: 35866075 Free PMC article. Review.

10

Tumor vessel normalization and immunotherapy in gastric cancer.

Yu X, He S, Shen J, Huang Q, Yang P, Huang L, Pu D, Wang L, Li L, Liu J, Liu Z, Zhu L. Yu X, et al. Among authors: li l. Ther Adv Med Oncol. 2022 Jul 18;14:17588359221110176. doi: 10.1177/17588359221110176. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35872968 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results